近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Davies, K., Mercer, J., Chen, N., Double, K. (2016). Copper dyshomoeostasis in Parkinson's disease: Implications for pathogenesis and indications for novel therapeutics. Clinical Science, 130(8), 565-574. [More Information] Hare, D., Double, K. (2016). Iron and dopamine: A toxic couple. Brain, 139(4), 1026-1035. [More Information] Davies, K., Hare, D., Bohic, S., James, S., Billings, J., Finkelstein, D., Doble, P., Double, K. (2015). Comparative Study of Metal Quantification in Neurological Tissue Using Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry Imaging and X-ray Fluorescence Microscopy. Analytical Chemistry, 87(13), 6639-6645. [More Information] Purves-Tyson, T., Boerrigter, D., Allen, K., Zavitsanou, K., Karl, T., Djunaidi, V., Double, K., Desai, R., Handelsman, D., Weickert, C. (2015). Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats. Hormones and Behavior, 70, 73-84. [More Information] Todd, G., Haberfield, M., Faulkner, P., Hayes, M., Wilcox, R., Rae, C., Bulathsinhala, T., Grunstein, R., Yee, B., Double, K. (2015). Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease). Clinical Neurophysiology, 126(4), 736-742. [More Information] Schroeder, R., Double, K., Gerber, J. (2015). Using Sepia melanin as a PD model to describe the binding characteristics of neuromelanin - A critical review. Journal of Chemical Neuroanatomy, 64-65, 20-32. [More Information] Davies, K., Bohic, S., Carmona, A., Ortega, R., Cottam, V., Hare, D., Finberg, J., Reyes, S., Halliday, G., Mercer, J., Double, K. (2014). Copper pathology in vulnerable brain regions in Parkinson's disease. Neurobiology of Aging, 35(4), 858-866. [More Information] Todd, G., Haberfield, M., Faulkner, P., Rae, C., Hayes, M., Wilcox, R., Taylor, J., Gandevia, S., Godau, J., Berg, D., Double, K., et al (2014). Hand function is impaired in healthy older adults at risk of Parkinson's disease. Journal of Neural Transmission, 121(11), 1377-1386. [More Information] Hall, H., Reyes, S., Landeck, N., Bye, C., Leanza, G., Double, K., Thompson, L., Halliday, G., Kirik, D. (2014). Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain, 137(9), 2493-2508. [More Information] Purves-Tyson, T., Owens, S., Double, K., Desai, R., Handelsman, D., Weickert, C. (2014). Testosterone Induces Molecular Changes in Dopamine Signaling Pathway Molecules in the Adolescent Male Rat Nigrostriatal Pathway. PloS One, 9(3), 1-12. [More Information] Dang, T., Dobson-Stone, C., Glaros, E., Kim, W., Hallupp, M., Bartley, L., Piguet, O., Hodges, J., Halliday, G., Double, K., et al (2013). Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model. Disease Models and Mechanisms, 6(5), 1198-1204. [More Information] Davies, K., Hare, D., Cottam, V., Chen, N., Hilgers, L., Halliday, G., Mercer, J., Double, K. (2013). Localization of copper and copper transporters in the human brain. Metallomics, 5(1), 43-51. [More Information] Reyes, S., Fu, Y., Double, K., Cottam, V., Thompson, L., Kirik, D., Paxinos, G., Watson, C., Cooper, H., Halliday, G. (2013). Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease. Neurobiology of Aging, 34(3), 873-886. [More Information] Reyes, S., Cottam, V., Kirik, D., Double, K., Halliday, G. (2013). Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra. Movement Disorders, 28(10), 1351-1359. [More Information] Reyes, S., Fu, Y., Double, K., Thompson, L., Kirik, D., Paxinos, G., Halliday, G. (2012). GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area. The Journal of Comparative Neurology, 520(12), 2591-2607. [More Information] Chan, S., Dunlop, R., Rowe, A., Double, K., Rodgers, K. (2012). L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro. Experimental Neurology, 238(1), 29-37. [More Information] Double, K. (2012). Neuronal vulnerability in Parkinson's disease. Parkinsonism and Related Disorders, 18(Suppl 1), S52-S54. [More Information] Purves-Tyson, T., Handelsman, D., Double, K., Owens, S., Bustamante, S., Weickert, C. (2012). Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra. BMC Neuroscience, 13(1), 1-12. [More Information] Kurz, A., Double, K., Lastres-Becker, I., Tozzi, A., Tantucci, M., Bockhart, V., Bonin, M., Garcia-Arencibia, M., Nuber, S., Schlaudraff, F. (2010). A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PloS One, 5(7), 1-15. [More Information] Werry, E., Enjeti, S., Halliday, G., Sachdev, P., Double, K. (2010). Effect of age on proliferation-regulating factors in human adult neurogenic areas. Journal of Neurochemistry, 115(4), 956-964. [More Information]